The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New...
The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology
About this item
Full title
Author / Creator
Publisher
Egypt: Hindawi Publishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Egypt: Hindawi Publishing Corporation
Subjects
More information
Scope and Contents
Contents
Aims. The differences between the 2007 and the 2013 ASCO/CAP HER2 guidelines have been compared. We also discussed the potential consequences in our pathological practice. Material and Methodology. 189 HER2 fluorescence in situ hybridisation (FISH) tests were performed from 1016 preliminary HER2 immunohistochemical tests (IHC). All cases were revie...
Alternative Titles
Full title
The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4040196
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4040196
Other Identifiers
ISSN
2090-5661,2090-567X
E-ISSN
2090-567X
DOI
10.1155/2014/793695
